- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Exemestane
Total 268 results
-
Taizhou EOC Pharma Co., Ltd.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
National Cancer Centre, SingaporeUnknown
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Calithera Biosciences, IncCompleted
-
Kyowa Kirin Co., Ltd.Completed
-
Taizhou EOC Pharma Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
Hamdy A. AzimRecruitingPalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)Metastatic Breast CancerSouth Africa
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedNeoplasms | Neoplasms by Site | Ovarian Diseases | Adnexal Diseases | Endocrine Gland Neoplasms | Ovarian Neoplasms | Genital Diseases, Female
-
Eli Lilly and CompanyRecruitingBreast Neoplasms | Neoplasm MetastasisJapan, United States, China, Czechia, Belgium, Brazil, Germany, Netherlands, Russian Federation, Ukraine, Taiwan, France, Korea, Republic of, Italy, Spain, Australia, Turkey, India, Argentina, Greece, Austria, Mexico
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical HyperplasiaUnited States
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationTerminated
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Hong Kong, Taiwan, Malaysia, Thailand, Argentina, Belgium, Portugal
-
Novartis PharmaceuticalsCompleted
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsSpain, United States, Belgium, Italy, Germany, France, Greece, United Kingdom, Portugal, Australia, Canada
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationCompleted
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
PfizerInternational Collaborative Cancer GroupCompletedBreast NeoplasmsAustralia, Denmark, Netherlands, United States, Bulgaria, Hungary, Italy, Spain, Belgium, Czech Republic, Ireland, Poland, Russian Federation, Sweden, United Kingdom, Croatia, Serbia, Germany, Bosnia and Herzegovina, Norway, South... and more
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States
-
Baylor Breast Care CenterPfizerTerminatedMetastatic Breast CancerUnited States
-
NYU Langone HealthCompleted
-
Fondazione Sandro PitiglianiCompleted
-
Inge Marie SvaneWithdrawn
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
Region Örebro CountyMid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala,...Not yet recruiting
-
Syndax PharmaceuticalsCompletedBreast Cancer | Lung Cancer | Non Small Cell Lung Cancer (NSCLC) | Estrogen Receptor Breast CancerUnited States
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Belgium, Canada, Korea, Republic of, Portugal, France, United Kingdom, China, Germany, Japan, Mexico, Thailand, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Poland, Romania, Chile, Sw... and more
-
wang shusenRecruiting
-
National Cancer Institute (NCI)CompletedStage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage 0 Breast Cancer AJCC v6 and v7United States, Italy
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Institut Claudius RegaudPHARMACIA SASCompleted
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States